Algisys

Pharma

Biotech company that makes omega-3 oils from algae raises $2.5M

A biotechnology startup that’s developed a manufacturing process for producing omega-3 fatty acids from algae has closed $2.5 million of an anticipated $5 million series A round. Two AlgiSys executives — CEO Michael LoPresti and chief technology officer Charles Roe — confirmed the funding but were hesitant to reveal much more because the round is […]